Table 1.
Clinical Characteristics of Patients with T-ALL Analyzed by Array CGH
| Characteristic | Patients With Treatment Failure (n = 22) |
Long-Term Survivors (n = 25) |
P | ||
|---|---|---|---|---|---|
| No. | % | No. | % | ||
| Age, years | .83 | ||||
| Median | 10.5 | 10 | |||
| Range | 3-17 | 2-17 | |||
| WBC at diagnosis, ×109/L | .69 | ||||
| Median | 216 | 161 | |||
| Range | 15-875 | 17-643 | |||
| Mediastinal mass | 7 of 22 | 32 | 13 of 25 | 52 | .23 |
| Sex | |||||
| Female | 6 of 22 | 27 | 6 of 25 | 24 | 1.00 |
| CNS status* | |||||
| 1 | 12 of 22 | 55 | 15 of 24 | 62 | .92 |
| 2 | 6 of 22 | 27 | 6 of 24 | 25 | |
| 3 | 4 of 22 | 18 | 3 of 24 | 13 | |
Abbreviations: T-ALL, T-cell acute lymphoblastic leukemia; CGH, comparative genomic hybridization.
*
No CNS data available for one long-term survivor.